The American Journal of Medicine
Volume 123, Issue 3 , Pages 213-216, March 2010

Diabetic Retinopathy: An Update on Treatment

  • Ryan J. Fante, BS

      Affiliations

    • University of Colorado School of Medicine, Denver, Colo
  • ,
  • Vikram D. Durairaj, MD

      Affiliations

    • Department of Ophthalmology, Rocky Mountain Lions Eye Institute, University of Colorado Denver, Aurora, Colo
  • ,
  • Scott C.N. Oliver, MD

      Affiliations

    • University of Colorado School of Medicine, Denver, Colo
    • Department of Ophthalmology, Rocky Mountain Lions Eye Institute, University of Colorado Denver, Aurora, Colo
    • Corresponding Author InformationRequests for reprints should be addressed to Scott C.N. Oliver, MD, Department of Ophthalmology, Rocky Mountain Lions Eye Institute, University of Colorado Denver, PO Box 6510, Mail Stop F731, Aurora, CO 80045

Abstract 

Diabetic retinopathy is a progressive disease that results from vascular injury due to chronic hyperglycemia. It is the leading cause of blindness in working-age adults in the US and is usually asymptomatic until late stages. Treatment with laser photocoagulation is effective at preventing severe vision loss; thus, diabetic patients should be referred for regular screening by an ophthalmologist. New inhibitors of vascular endothelial growth factor may provide targeted nonsurgical treatment to improve vision in diabetic retinopathy.

Keywords: Antiangiogenic therapy, Diabetic retinopathy, Intravitreal injection, Laser photocoagulation, Macular edema, Neovascularization, Retina, Vascular Endothelial Growth Factor, Vitrectomy

 

 Funding: None.

 Conflict of Interest: None.

 Authorship: All authors participated in the preparation of the manuscript.

PII: S0002-9343(09)01006-7

doi:10.1016/j.amjmed.2009.09.020

The American Journal of Medicine
Volume 123, Issue 3 , Pages 213-216, March 2010